Loading company…
Riskpilot
← Back to search
Sign in
Get full access
SØR APOTEK AS
AS
Active
Org 926424777
Lumberveien 5, 4621 Kristiansand S
Retail sale of pharmaceutical products · NACE 4773
Est. 2021
15 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 23M
+20% vs 2023
EBITDA margin
3.3%
+82% vs 2023
Equity ratio
13.6%
Financial strength
Net profit 2024
NOK 510K
+150% vs 2023
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
0M
2021
0M
0%
2022
0M
0%
2023
1M
+100%
2024
Key figures
Annual report 2024
Revenue
NOK 23M
+20%
EBITDA
NOK 762K
+82%
Net profit
NOK 510K
+150%
Total assets
NOK 4,4M
-14%
Equity
NOK 598K
+36%
Employees
15
—
Company information
Legal name
SØR APOTEK AS
Org number
926424777
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
20. januar 2021
Share capital
NOK 30 000
Employees
15 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Kjøp, salg av apotekvarer og dertil tilhørende tjenester.
Contact
Address
Lumberveien 5, 4621 Kristiansand S
Phone
+4737390080
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Kristiansand
All Norway companies
Revenue
NOK millions
0M
7M
13M
20M
26M
5M
2021
13M
2022
19M
2023
23M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
1M
2024
Income statement
NOK thousands
Item
2021
2022
2023
2024
Revenue
4 590
13 083
19 272
23 040
Staff expenses
−921
−2 353
−3 453
−3 972
EBITDA
−22
400
418
762
Depreciation & amort.
−40
−69
−69
−69
EBIT
−62
331
349
693
Net financials
−1
0
−87
−39
Profit before tax
−63
331
262
654
Tax
−15
73
58
144
Net profit
−48
258
204
510
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
Total assets
4 093
4 362
5 155
4 411
Equity
−24
235
439
598
Long-term debt
1 963
1 890
1 593
289
Short-term debt
2 154
2 237
3 124
3 524
Total debt
4 117
4 127
4 717
3 813
Financial ratios
5-year trend
EBITDA margin
3.3%
This company
15.8%
Market median
-79% vs market
2021
2024
Equity ratio
13.6%
This company
38.2%
Market median
-64% vs market
2021
2024
Return on equity
85.2%
This company
18.4%
Market median
+363% vs market
2021
2024
Net profit margin
2.2%
This company
8.1%
Market median
-73% vs market
2021
2024
Asset turnover
5.22×
This company
1.12×
Market median
+366% vs market
2021
2024
Debt / equity
6.37×
This company
0.62×
Market median
-927% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-02 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
EH
Erik Helgemo
Chief Executive Officer
Chief Executive Officer
2021
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
MT
Minh-Anh Thuy Do
Chairman
2021
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Fiat Holding As
Company
50%
50%
2022
Jolama Holding As
Company
50%
50%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Fiat Holding As
SØR APOTEK AS
(this company)
Board network connections
Board members of SØR APOTEK AS also hold positions in
0
other companies.
Person
Role here
Other companies
Erik Helgemo
Chief Executive Officer
0 companies
Minh-Anh Thuy Do
Chairman
0 companies